Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149688268> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2149688268 endingPage "1591" @default.
- W2149688268 startingPage "1591" @default.
- W2149688268 abstract "SIR, We welcome the collective efforts of Dr Chakravarty and colleagues [1] in producing current revised guidelines on the DMARD therapy in consultation with the British Association of Dermatologists. Undoubtedly a lot of attention and effort had gone into bringing these guidelines up to date. Active collaboration of the British Society for Rheumatology (BSR), British Health Professionals in Rheumatology (BHPR) and British Association of Dermatologists in a unified team capitalizes on diverse skills and ideas. We feel however that, when this theme is next re-visited the following concern should also be addressed. Concomitant use of MTX with radiotherapy had known to cause radiation recall dermatitis [2]. Radiation recall dermatitis refers to an inflammatory skin reaction at a previously irradiated field subsequent to chemotherapy administration. MTX is one of the agents reported to cause this phenomenon [2]. Recently, we have come across patients on established MTX therapy for inflammatory arthritis, who have had to be switched to an alternative DMARD after receiving radiotherapy for various malignancies. Food and Drug Administration (FDA) had issued warnings about possible soft tissue and osteonecrosis in this situation (www.fda.gov/CDER/foi/label/2004/11719slr106_ methotrexate_lbl.pdf). The risk exists for many years after the radiotherapy has been given and for these patients further MTX is contra-indicated. As there are no formal guidelines on this particular issue, future guideline developers should consider this not very uncommon patient population. When this guidance is next revised we suggest that input from an oncologist may be valuable and would help to broaden the guidance on DMARD therapy. Disclosure statement: The authors have declared no conflicts of interest." @default.
- W2149688268 created "2016-06-24" @default.
- W2149688268 creator A5035454245 @default.
- W2149688268 creator A5091004391 @default.
- W2149688268 date "2008-08-13" @default.
- W2149688268 modified "2023-09-23" @default.
- W2149688268 title "Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists" @default.
- W2149688268 cites W2002208193 @default.
- W2149688268 cites W2106550996 @default.
- W2149688268 doi "https://doi.org/10.1093/rheumatology/ken322" @default.
- W2149688268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18676499" @default.
- W2149688268 hasPublicationYear "2008" @default.
- W2149688268 type Work @default.
- W2149688268 sameAs 2149688268 @default.
- W2149688268 citedByCount "2" @default.
- W2149688268 countsByYear W21496882682022 @default.
- W2149688268 crossrefType "journal-article" @default.
- W2149688268 hasAuthorship W2149688268A5035454245 @default.
- W2149688268 hasAuthorship W2149688268A5091004391 @default.
- W2149688268 hasBestOaLocation W21496882681 @default.
- W2149688268 hasConcept C126322002 @default.
- W2149688268 hasConcept C142724271 @default.
- W2149688268 hasConcept C16005928 @default.
- W2149688268 hasConcept C177713679 @default.
- W2149688268 hasConcept C1862650 @default.
- W2149688268 hasConcept C2779134260 @default.
- W2149688268 hasConcept C2780035454 @default.
- W2149688268 hasConcept C2780182762 @default.
- W2149688268 hasConcept C3020647791 @default.
- W2149688268 hasConcept C512399662 @default.
- W2149688268 hasConcept C71924100 @default.
- W2149688268 hasConcept C98274493 @default.
- W2149688268 hasConceptScore W2149688268C126322002 @default.
- W2149688268 hasConceptScore W2149688268C142724271 @default.
- W2149688268 hasConceptScore W2149688268C16005928 @default.
- W2149688268 hasConceptScore W2149688268C177713679 @default.
- W2149688268 hasConceptScore W2149688268C1862650 @default.
- W2149688268 hasConceptScore W2149688268C2779134260 @default.
- W2149688268 hasConceptScore W2149688268C2780035454 @default.
- W2149688268 hasConceptScore W2149688268C2780182762 @default.
- W2149688268 hasConceptScore W2149688268C3020647791 @default.
- W2149688268 hasConceptScore W2149688268C512399662 @default.
- W2149688268 hasConceptScore W2149688268C71924100 @default.
- W2149688268 hasConceptScore W2149688268C98274493 @default.
- W2149688268 hasIssue "10" @default.
- W2149688268 hasLocation W21496882681 @default.
- W2149688268 hasLocation W21496882682 @default.
- W2149688268 hasOpenAccess W2149688268 @default.
- W2149688268 hasPrimaryLocation W21496882681 @default.
- W2149688268 hasRelatedWork W1977039195 @default.
- W2149688268 hasRelatedWork W2082482010 @default.
- W2149688268 hasRelatedWork W2128434532 @default.
- W2149688268 hasRelatedWork W2738981461 @default.
- W2149688268 hasRelatedWork W3213299891 @default.
- W2149688268 hasRelatedWork W4231870048 @default.
- W2149688268 hasRelatedWork W4234833016 @default.
- W2149688268 hasRelatedWork W4249487090 @default.
- W2149688268 hasRelatedWork W4297184974 @default.
- W2149688268 hasRelatedWork W4306179204 @default.
- W2149688268 hasVolume "47" @default.
- W2149688268 isParatext "false" @default.
- W2149688268 isRetracted "false" @default.
- W2149688268 magId "2149688268" @default.
- W2149688268 workType "article" @default.